临床变量与系统性硬化症内在分子亚型关联的基因组荟萃分析
该研究对311例系统性硬化症(SSc)患者皮肤活检的公共基因表达数据进行内在分子亚型分类,并以ASSET试验84例参与者的RNA测序数据作为验证队列,分析基线人口学与内在分子亚型的关联。结果显示男性更易归为纤维增殖型,非洲裔美国/黑人患者归为纤维增殖型的可能性是白种人/高加索人的2.5倍,抗RNA聚合酶I和III抗体阳性者富集于炎症型,抗Scl-70富集于纤维增殖型,炎症型和纤维增殖型平均mRSS高于正常样型,炎症型平均病程短于纤维增殖型和正常样型。
要点
- 男性更易被分类为纤维增殖型内在分子亚型(P=0.0046)。
- 非洲裔美国/黑人患者归为纤维增殖型的可能性是白种人/高加索人的2.5倍(P=0.0378)。
- 抗RNA聚合酶I和III抗体阳性者富集于炎症型,抗Scl-70富集于纤维增殖型。
核心结论
- 研究识别出内在分子亚型间多个基线人口学变量的统计学显著差异,这些差异可能反映疾病发病机制的基础特征(如纤维化的时间阶段),并对某些SSc人群更可能起效的治疗具有意义。
研究设计与样本
- 对311例SSc患者皮肤活检的公共DNA微阵列基因表达数据进行内在分子亚型分类,并以ASSET试验84例参与者的RNA测序数据作为验证队列,检验基线临床人口学与内在分子亚型的统计学显著关联。
主要发现
- 男性更易被分类为纤维增殖型亚型(P=0.0046)。
- 自我认同为非洲裔美国/黑人的SSc患者归为纤维增殖型的可能性是白种人/高加索人的2.5倍(P=0.0378)。
- ASSET参与者中抗RNA聚合酶I和抗RNA聚合酶III自身抗体阳性者富集于炎症型亚型(P=5.8×10^-5,P=9.3×10^-5),抗Scl-70富集于纤维增殖型亚型。
- 炎症型和纤维增殖型的平均改良Rodnan皮肤评分(mRSS)统计学上高于正常样型(P=0.0027)。
- 炎症型的平均病程短于纤维增殖型和正常样型内在分子亚型(P=8.8×10^-4)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Four intrinsic molecular subsets (inflammatory, fibroproliferative, limited, normal-like) have previously been identified in SSc and are characterized by unique gene expression signatures and pathways. The intrinsic subsets have been linked to improvement with specific therapies. Here, we investigated associations between baseline demographics and intrinsic molecular subsets in a meta-analysis of published datasets. METHODS: Publicly available gene expression data from skin biopsies of 311 SSc patients measured by DNA microarray were classified into the intrinsic molecular subsets. RNA-sequencing data from 84 participants from the ASSET trial were used as a validation cohort. Baseline clinical demographics and intrinsic molecular subsets were tested for statistically significant associations. RESULTS: Males were more likely to be classified in the fibroproliferative subset (P = 0.0046). SSc patients who identified as African American/Black were 2.5 times more likely to be classified as fibroproliferative compared with White/Caucasian patients (P = 0.0378). ASSET participants sera positive for anti-RNA pol I and RNA pol III autoantibodies were enriched in the inflammatory subset (P = 5.8 × 10-5, P = 9.3 × 10-5, respectively), while anti-Scl-70 was enriched in the fibroproliferative subset. Mean modified Rodnan Skin Score (mRSS) was statistically higher in the inflammatory and fibroproliferative subsets compared with normal-like (P = 0.0027). The average disease duration for inflammatory subset was less than fibroproliferative and normal-like intrinsic subsets (P = 8.8 × 10-4). CONCLUSIONS: We identified multiple statistically significant differences in baseline demographics between the intrinsic subsets that may represent underlying features of disease pathogenesis (e.g. chronological stages of fibrosis) and have implications for treatments that are more likely to work in certain SSc populations.
引用
- Franks JM, Toledo DM, Martyanov V, et al. A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosis. Rheumatology (Oxford). 2022. PMID: 35751592. doi:10.1093/rheumatology/keac344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。